Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, has announced that Forty Seven Inc., a new biotechnology company specializing in cancer immunotherapy, is powering two upcoming anti-cancer studies with the ...
read more
Tuesday, November 16, 2021
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with the global, science-led ...
read more
Wednesday, January 12, 2022
Malvern Panalytical announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.
read more
Horizon Discovery Group announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines.
read more
Vantage Consulting Group has become the first systems integrator to join the Pharma & Biopharma Outsourcing Association (PBOA).
read more
Monday, February 13, 2023
Quotient Sciences announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility.
read more
Wednesday, September 17, 2025
Crown Bioscience announced the opening of a state-of-the-art model development center in Kannapolis, North Carolina. This strategic investment expands the company’s operations and enhances its ability to deliver advanced preclinical oncology models, ...
read more
TrialCard announced the acquisition of RxSolutions, a company that specializes in customized pharmaceutical reimbursement programs for both commercial and clinical supply professionals.
read more
Wednesday, January 06, 2016
Rodin Therapeutics, a biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, today announced preferred stock financing commitments totaling $17.3M from Atlas Venture and Biogen. In addition ...
read more
ProBioGen, a CDMO of complex glycoproteins and corresponding technologies, has announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics.
read more
CARsgen Therapeutics announced the opening of its new manufacturing facility in Shanghai.
read more
CordenPharma Group announced the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August 1, 2019.
read more
Tuesday, October 08, 2019
SwRI has received new funding from the MTEC and the FDA to use a SwRI-developed bioreactor to propagate cells for personalized regenerative medicine applications.
read more
Convey Health Solutions has announced the opening of a new distribution facility and creation of more than 40 jobs in Lenexa, Kansas.
read more
AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research.
read more